Biopharma Seeks Sunlight On Disclosure Regulations
WASHINGTON – Still in the dark about how the government wants them to collect data about their payments to doctors beginning Jan. 1, 2012, drugmakers are seeking a little leniency and some swift clarity about what's expected of them under the Physicians Payment Sunshine provision.
Since the Department of Health and Human Services (HHS) missed its Oct.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter